Search

Home > New FDA Approvals > 141 – Hemospray for GI bleeding; atezolizumab priority review in initial NSCLC; FDA requiring restaurants to post calorie counts
Podcast: New FDA Approvals
Episode:

141 – Hemospray for GI bleeding; atezolizumab priority review in initial NSCLC; FDA requiring restaurants to post calorie counts
Category: Science & Medicine
Duration: 00:08:19
Publish Date: 2018-05-08 06:00:00
Description:

May 8, 2018 

Please subscribe, rate and review if you like this podcast. Thank you! The podcast website is http://newfdaapprovals.com

1:25 FDA permits marketing of new endoscopic device for treating gastrointestinal bleeding https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm606799.htm

3:10 FDA grants priority review to Roche’s cancer immunotherapy TECENTRIQ (atezolizumab) for initial treatment of people with a specific type of metastatic lung cancer https://www.roche.com/media/store/releases/med-cor-2018-05-07.htm 

5:45 FDA requiring restaurants to post calorie counts https://www.upi.com/FDA-requiring-restaurants-to-post-calorie-counts/6511525699017/ https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm606694.htm 

Brought to you by Nascent Medical. For assistance with medical writing, please email info@nascentmc.com.

Music credit: freemusicarchive.org/music/MindsEye/Yellow_Taxi/
Total Play: 0